Sun Pharma Announces USFDA Tentative Approval for Generic Rilutek (riluzole)

Sun Pharma, a generic drug manufacturing company based in India, is poised to provide patients with a generic version of Sanofi Aventis’ Rilutek, the only FDA approved ALS drug generating an annual revenue of $50 million in the US.

Click here to read more.

Share this: